Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 35 entries
Sorted by: Best Match Show Resources per page
Diabetes quiz. How much do you know about diabetes and heart disease?.

Diabetes self-management

Wiley F.
PMID: 26521604
Diabetes Self Manag. 2015 Sep-Oct;32(5):12, 14.

No abstract available.

Cite
Wiley F. Diabetes quiz. How much do you know about diabetes and heart disease?. Diabetes Self Manag. 2015;32(5):12, 14
Wiley, F. (2015). Diabetes quiz. How much do you know about diabetes and heart disease?. Diabetes self-management, 32(5), 12, 14.
Wiley, Frieda. "Diabetes quiz. How much do you know about diabetes and heart disease?." Diabetes self-management vol. 32,5 (2015): 12, 14.
Wiley F. Diabetes quiz. How much do you know about diabetes and heart disease?. Diabetes Self Manag. 2015 Sep-Oct;32(5):12, 14. PMID: 26521604.
Copy Download .nbib Format: NLM
[Risk factors for heart failure in women: diabetes].

Giornale italiano di cardiologia (2006)

Russo G, Cherubini A, Faganello G, Candido R, Di Lenarda A.
PMID: 23678529
G Ital Cardiol (Rome). 2012 May;13(5):12S-17S.

Diabetes mellitus has become increasingly prevalent in recent years, the most dramatic increase being observed in younger women. Diabetes is a multiplier of cardiovascular risk and decreases life expectancy more in women than in men. Diabetic women are less...

Cite
Russo G, Cherubini A, Faganello G, et al. I fattori di rischio per lo scompenso cardiaco nella donna: il diabete. [Risk factors for heart failure in women: diabetes]. G Ital Cardiol (Rome). 2012;13(5):12S-17S
Russo, G., Cherubini, A., Faganello, G., Candido, R., & Di Lenarda, A. (2012). I fattori di rischio per lo scompenso cardiaco nella donna: il diabete. [Risk factors for heart failure in women: diabetes]. Giornale italiano di cardiologia (2006), 13(5), 12S-17S.
Russo, Giulia, et al. "I fattori di rischio per lo scompenso cardiaco nella donna: il diabete." [Risk factors for heart failure in women: diabetes]. Giornale italiano di cardiologia (2006) vol. 13,5 (2012): 12S-17S.
Russo G, Cherubini A, Faganello G, Candido R, Di Lenarda A. I fattori di rischio per lo scompenso cardiaco nella donna: il diabete. [Risk factors for heart failure in women: diabetes]. G Ital Cardiol (Rome). 2012 May;13(5):12S-17S. Italian. PMID: 23678529.
Copy Download .nbib Format: NLM
Diabetes Complications in Racial and Ethnic Minority Populations in the USA.

Current diabetes reports

Haw JS, Shah M, Turbow S, Egeolu M, Umpierrez G.
PMID: 33420878
Curr Diab Rep. 2021 Jan 09;21(1):2. doi: 10.1007/s11892-020-01369-x.

PURPOSE OF REVIEW: Racial and ethnic minority populations have a higher burden of diabetes-related complications. There have been many epidemiologic studies to better define these racial/ethnic disparities in diabetes outcomes with additional studies offering interventions to mitigate them. This...

Cite
Haw JS, Shah M, Turbow S, et al. Diabetes Complications in Racial and Ethnic Minority Populations in the USA. Curr Diab Rep. 2021;21(1):2doi: 10.1007/s11892-020-01369-x.
Haw, J. S., Shah, M., Turbow, S., Egeolu, M., & Umpierrez, G. (2021). Diabetes Complications in Racial and Ethnic Minority Populations in the USA. Current diabetes reports, 21(1), 2. https://doi.org/10.1007/s11892-020-01369-x
Haw, J Sonya, et al. "Diabetes Complications in Racial and Ethnic Minority Populations in the USA." Current diabetes reports vol. 21,1 (2021): 2. doi: https://doi.org/10.1007/s11892-020-01369-x
Haw JS, Shah M, Turbow S, Egeolu M, Umpierrez G. Diabetes Complications in Racial and Ethnic Minority Populations in the USA. Curr Diab Rep. 2021 Jan 09;21(1):2. doi: 10.1007/s11892-020-01369-x. PMID: 33420878; PMCID: PMC7935471.
Copy Download .nbib Format: NLM
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.

Frontiers in endocrinology

Corrao S, Pinelli K, Vacca M, Raspanti M, Argano C.
PMID: 33868163
Front Endocrinol (Lausanne). 2021 Mar 31;12:609470. doi: 10.3389/fendo.2021.609470. eCollection 2021.

The pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than one hundred million individuals, including more than two million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide...

Cite
Corrao S, Pinelli K, Vacca M, et al. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Front Endocrinol (Lausanne). 2021;12:609470doi: 10.3389/fendo.2021.609470.
Corrao, S., Pinelli, K., Vacca, M., Raspanti, M., & Argano, C. (2021). Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Frontiers in endocrinology, 12609470. https://doi.org/10.3389/fendo.2021.609470
Corrao, Salvatore, et al. "Type 2 Diabetes Mellitus and COVID-19: A Narrative Review." Frontiers in endocrinology vol. 12 (2021): 609470. doi: https://doi.org/10.3389/fendo.2021.609470
Corrao S, Pinelli K, Vacca M, Raspanti M, Argano C. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Front Endocrinol (Lausanne). 2021 Mar 31;12:609470. doi: 10.3389/fendo.2021.609470. eCollection 2021. PMID: 33868163; PMCID: PMC8044543.
Copy Download .nbib Format: NLM
Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort.

Diabetes research and clinical practice

Mather KJ, Bebu I, Baker C, Cohen RM, Crandall JP, DeSouza C, Green JB, Kirkman MS, Krause-Steinrauf H, Larkin M, Pettus J, Seaquist ER, Soliman EZ, Schroeder EB, Wexler DJ, Pop-Busui R.
PMID: 32450102
Diabetes Res Clin Pract. 2020 Jul;165:108235. doi: 10.1016/j.diabres.2020.108235. Epub 2020 May 23.

AIMS: The Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) trial is a randomized clinical trial comparing glycemic effects of four diabetes medications added to metformin in type 2 diabetes (T2D). Microvascular and macrovascular diseases are secondary...

Cite
Mather KJ, Bebu I, Baker C, et al. Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort. Diabetes Res Clin Pract. 2020;165:108235doi: 10.1016/j.diabres.2020.108235.
Mather, K. J., Bebu, I., Baker, C., Cohen, R. M., Crandall, J. P., DeSouza, C., Green, J. B., Kirkman, M. S., Krause-Steinrauf, H., Larkin, M., Pettus, J., Seaquist, E. R., Soliman, E. Z., Schroeder, E. B., Wexler, D. J., Pop-Busui, R. (2020). Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort. Diabetes research and clinical practice, 165108235. https://doi.org/10.1016/j.diabres.2020.108235
Mather, Kieren J, et al. "Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort." Diabetes research and clinical practice vol. 165 (2020): 108235. doi: https://doi.org/10.1016/j.diabres.2020.108235
Mather KJ, Bebu I, Baker C, Cohen RM, Crandall JP, DeSouza C, Green JB, Kirkman MS, Krause-Steinrauf H, Larkin M, Pettus J, Seaquist ER, Soliman EZ, Schroeder EB, Wexler DJ, Pop-Busui R. Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort. Diabetes Res Clin Pract. 2020 Jul;165:108235. doi: 10.1016/j.diabres.2020.108235. Epub 2020 May 23. PMID: 32450102; PMCID: PMC7416515.
Copy Download .nbib Format: NLM
Cancer, diabetes, and angiotensin blockade: a question of hypohydration.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Thornton SN.
PMID: 21947832
J Clin Oncol. 2011 Nov 20;29(33):4465-6. doi: 10.1200/JCO.2011.38.2069. Epub 2011 Sep 26.

No abstract available.

Cite
Thornton SN. Cancer, diabetes, and angiotensin blockade: a question of hypohydration. J Clin Oncol. 2011;29(33):4465-6doi: 10.1200/JCO.2011.38.2069.
Thornton, S. N. (2011). Cancer, diabetes, and angiotensin blockade: a question of hypohydration. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29(33), 4465-6. https://doi.org/10.1200/JCO.2011.38.2069
Thornton, Simon N. "Cancer, diabetes, and angiotensin blockade: a question of hypohydration." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29,33 (2011): 4465-6. doi: https://doi.org/10.1200/JCO.2011.38.2069
Thornton SN. Cancer, diabetes, and angiotensin blockade: a question of hypohydration. J Clin Oncol. 2011 Nov 20;29(33):4465-6. doi: 10.1200/JCO.2011.38.2069. Epub 2011 Sep 26. PMID: 21947832.
Copy Download .nbib Format: NLM
Addressing the burden of diabetes.

JAMA

Seaquist ER.
PMID: 24915253
JAMA. 2014 Jun 11;311(22):2267-8. doi: 10.1001/jama.2014.6451.

No abstract available.

Cite
Seaquist ER. Addressing the burden of diabetes. JAMA. 2014;311(22):2267-8doi: 10.1001/jama.2014.6451.
Seaquist, E. R. (2014). Addressing the burden of diabetes. JAMA, 311(22), 2267-8. https://doi.org/10.1001/jama.2014.6451
Seaquist, Elizabeth R. "Addressing the burden of diabetes." JAMA vol. 311,22 (2014): 2267-8. doi: https://doi.org/10.1001/jama.2014.6451
Seaquist ER. Addressing the burden of diabetes. JAMA. 2014 Jun 11;311(22):2267-8. doi: 10.1001/jama.2014.6451. PMID: 24915253.
Copy Download .nbib Format: NLM
Are large sample size studies the answer to evaluate effects of drug use in non-clinical trial settings?.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Yang X, Chan JC.
PMID: 21947826
J Clin Oncol. 2011 Nov 20;29(33):4464-5; author reply 4466. doi: 10.1200/JCO.2011.37.9677. Epub 2011 Sep 26.

No abstract available.

Cite
Yang X, Chan JC. Are large sample size studies the answer to evaluate effects of drug use in non-clinical trial settings?. J Clin Oncol. 2011;29(33):4464-5; author reply 4466doi: 10.1200/JCO.2011.37.9677.
Yang, X., & Chan, J. C. (2011). Are large sample size studies the answer to evaluate effects of drug use in non-clinical trial settings?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29(33), 4464-5; author reply 4466. https://doi.org/10.1200/JCO.2011.37.9677
Yang, Xilin, and Chan, Juliana C N. "Are large sample size studies the answer to evaluate effects of drug use in non-clinical trial settings?." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29,33 (2011): 4464-5; author reply 4466. doi: https://doi.org/10.1200/JCO.2011.37.9677
Yang X, Chan JC. Are large sample size studies the answer to evaluate effects of drug use in non-clinical trial settings?. J Clin Oncol. 2011 Nov 20;29(33):4464-5; author reply 4466. doi: 10.1200/JCO.2011.37.9677. Epub 2011 Sep 26. PMID: 21947826.
Copy Download .nbib Format: NLM
New report calls for action on diabetes and its complications.

Disease management advisor

[No authors listed]
PMID: 17521049
Dis Manag Advis. 2007 May;13(5):59-60, 49.

Get serious about diabetes and its complications. That's what a new report says is necessary to get this troubling disease under control. The latest data about costs and prevalence are truly alarming and, in response, a consortium of organizations...

Cite
New report calls for action on diabetes and its complications. Dis Manag Advis. 2007;13(5):59-60, 49
(2007). New report calls for action on diabetes and its complications. Disease management advisor, 13(5), 59-60, 49.
"New report calls for action on diabetes and its complications." Disease management advisor vol. 13,5 (2007): 59-60, 49.
New report calls for action on diabetes and its complications. Dis Manag Advis. 2007 May;13(5):59-60, 49. PMID: 17521049.
Copy Download .nbib Format: NLM
Epidemiology of the diabetic heart.

Coronary artery disease

Tziakas DN, Chalikias GK, Kaski JC.
PMID: 16340402
Coron Artery Dis. 2005 Nov;16:S3-S10. doi: 10.1097/00019501-200511001-00002.

Diabetes mellitus is a worldwide epidemic. Cardiovascular disease remains the major cause of morbidity and mortality in people with diabetes. Studies have suggested that increased risk of cardiovascular disease is not restricted to type II or type I diabetes...

Cite
Tziakas DN, Chalikias GK, Kaski JC. Epidemiology of the diabetic heart. Coron Artery Dis. 2005;16:S3-S10doi: 10.1097/00019501-200511001-00002.
Tziakas, D. N., Chalikias, G. K., & Kaski, J. C. (2005). Epidemiology of the diabetic heart. Coronary artery disease, 16S3-S10. https://doi.org/10.1097/00019501-200511001-00002
Tziakas, Dimitrios N, et al. "Epidemiology of the diabetic heart." Coronary artery disease vol. 16 (2005): S3-S10. doi: https://doi.org/10.1097/00019501-200511001-00002
Tziakas DN, Chalikias GK, Kaski JC. Epidemiology of the diabetic heart. Coron Artery Dis. 2005 Nov;16:S3-S10. doi: 10.1097/00019501-200511001-00002. PMID: 16340402.
Copy Download .nbib Format: NLM
The "diabesity" epidemic: let's rehabilitate America.

MedGenMed : Medscape general medicine

Jones V.
PMID: 16926773
MedGenMed. 2006 May 08;8(2):34.

No abstract available.

Cite
Jones V. The "diabesity" epidemic: let's rehabilitate America. MedGenMed. 2006;8(2):34
Jones, V. (2006). The "diabesity" epidemic: let's rehabilitate America. MedGenMed : Medscape general medicine, 8(2), 34.
Jones, Val. "The "diabesity" epidemic: let's rehabilitate America." MedGenMed : Medscape general medicine vol. 8,2 (2006): 34.
Jones V. The "diabesity" epidemic: let's rehabilitate America. MedGenMed. 2006 May 08;8(2):34. PMID: 16926773; PMCID: PMC1785206.
Copy Download .nbib Format: NLM
Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Noto H, Tsujimoto T, Sasazuki T, Noda M.
PMID: 21454235
Endocr Pract. 2011 Jul-Aug;17(4):616-28. doi: 10.4158/EP10357.RA.

OBJECTIVE: To conduct a review and meta-analysis of the effect of diabetes mellitus on the incidence of and mortality attributable to cancer at any anatomic site.METHODS: We performed a search of MEDLINE and the Cochrane Library for pertinent articles...

Cite
Noto H, Tsujimoto T, Sasazuki T, et al. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract. 2011;17(4):616-28doi: 10.4158/EP10357.RA.
Noto, H., Tsujimoto, T., Sasazuki, T., & Noda, M. (2011). Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 17(4), 616-28. https://doi.org/10.4158/EP10357.RA
Noto, Hiroshi, et al. "Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. 17,4 (2011): 616-28. doi: https://doi.org/10.4158/EP10357.RA
Noto H, Tsujimoto T, Sasazuki T, Noda M. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract. 2011 Jul-Aug;17(4):616-28. doi: 10.4158/EP10357.RA. PMID: 21454235.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 35 entries